Legato Merger Corp. III (LEGT) Prices $175M IPO
by Marlena Haddad on 2024-02-05 at 5:11pm

Legato Merger Corp. III (NYSE: LEGT) announced the pricing of its $175 million IPO this evening. Its units are expected to begin trading on the NYSE American under the symbol “LEGT U” on Tuesday, February 6, 2024. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “LEGT” and “LEGT WS”, respectively.

Legato III intends to focus on target businesses in the infrastructure, engineering and construction, industrial and renewables industries.

The Company’s management team is comprised of Gregory Monahan, Chief Executive Officer and Director, Eric S. Rosenfeld, Chief SPAC Officer, Adam Jaffe, Chief Financial Officer, Secretary and Director, Brian Pratt, Director and Non-Executive Chairman of the Board, David D. Sgro, Director and Non-Executive Vice Chairman of the Board, and Adam Semler and John Ing, each a Director of the Company.

Total SPAC deal count for 2024 year-to-date is now 2. This offering is expected to close on Wednesday, February 7, 2024.


BTIG, LLC is acting as the sole book-running manager for the offering, with Craig-Hallum Capital Group LLC as co-manager.  Graubard Miller is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Equiniti Trust Company, LLC is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

by Nicholas Alan Clayton on 2024-10-23 at 8:56pm

Bold Eagle Acquisition Corp. announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BEAGU”, Thursday, October 24, 2024. The new SPAC plans to search for a combination target valued at $3 billion or more that would benefit from the relationships and experience...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved